---
title: Bravado Pharmaceuticals vs UPM Pharmaceuticals
slug_a: bravadopharm
slug_b: upm-inc
site: cdmo
review_signal_gate: closed
canonical_path: /compare/bravadopharm/upm-inc
---

# Bravado Pharmaceuticals vs UPM Pharmaceuticals

Side-by-side profile data from each company listing on this directory.

## Bravado Pharmaceuticals

- Profile: [/companies/bravadopharm](/companies/bravadopharm)

Bravado Pharmaceuticals — Bravado Pharmaceuticals is a Lutz, Florida pharmaceutical development company offering formulation development, analytical testing, and early-phase clinical manufacturing for client programs. It works across oral solid, injectable, and other dosage forms.

Services: 7. Modalities: 0. Indications: 0. Locations: 2. Certifications: 1. The strongest documented coverage currently appears in services (7).

### Services

- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Ophthalmic Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Combination Product Assembly & Final Packaging

### Modalities

- Data not yet provided.

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Product (DP)
- Oral Solid Dose (OSD)

## UPM Pharmaceuticals

- Profile: [/companies/upm-inc](/companies/upm-inc)

UPM Pharmaceuticals — Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.

Services: 12. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed